Clinical Trials Directory

Trials / Completed

CompletedNCT02219399

DHA Supplementation and Pregnancy Outcome

Maternal DHA Supplementation and Pregnancy Outcome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
871 (actual)
Sponsor
Colorado State University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Supplementation with DHA during pregnancy will increase gestational length and improve cognitive development.

Detailed description

This was a trial of supplementation with DHA during pregnancy to increase gestational length. Subjects were provided with 300 mg, 600 mg or placebo (olive oil) in a randomized design from week 24-26 of pregnancy until delivery. Gestational age, birth weight and birth length data were collected and infants growth at 2 and 4 months and cognitive development at 4 months and 1 year were measured.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT600 mg DHAPregnant women were given 600 mg DHA in the last trimester of pregnancy
DIETARY_SUPPLEMENT300 mg DHAPregnant women were given 300 mg DHA in the last trimester of pregnancy and through the first 3 months of breastfeeding
DIETARY_SUPPLEMENTPlaceboPregnant women in the control group received placebo of either olive oil or high oleic acid sunflower oil during the study period

Timeline

Start date
2001-01-01
Primary completion
2004-01-01
Completion
2014-01-01
First posted
2014-08-18
Last updated
2014-08-18

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02219399. Inclusion in this directory is not an endorsement.